AstraZeneca said the company's head of research and development, Martin Mackay, is leaving the company amid a senior-management shake-up by new Chief Executive Pascal Soriot.
WSJ.com: What's News US, Wall Street Journal
Tue, 01/15/2013 - 8:27am
AstraZeneca said the company's head of research and development, Martin Mackay, is leaving the company amid a senior-management shake-up by new Chief Executive Pascal Soriot.